Email This Release
Landmark ATHENA Study Findings With Multaq(R)(dronedarone) Show 24% Reduction in Cardiovascular Hospitalisation or Death in Patients With Atrial Fibrillation
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
